Ô¨Åcation
Patients who undergo revascularization for MAOD and
CMI are at risk for recurrent stenoses and recurrent symptoms. The incidence of these adverse events is greater after endovascular revascularization, as noted elsewhere in
this discussion. The presentation can range from asymptomatic stenoses to AMI and bowel infarction. Fortunately, the latter condition seems to be less common
and it is encouraging that the higher rate of recurrence
seen in the endovascular group